ExodusPoint Capital Management’s OptiNose OPTN Stock Holding History

ExodusPoint Capital Management’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-898	Closed	-$26K	–	2144
2023 Q1	$26K	Buy	+898	New	+$23.9K	﹤0.01%	1686
2021 Q3	–	Sell	-3,063	Closed	-$143K	–	2493
2021 Q2	$143K	Buy	+3,063	New	+$156K	﹤0.01%	2072
2021 Q1	–	Sell	-3,767	Closed	-$234K	–	2470
2020 Q4	$234K	Buy	+3,767	New	+$231K	﹤0.01%	1653
2019 Q4	–	Sell	-733	Closed	-$77K	–	1790
2019 Q3	$77K	Buy	+733	New	+$73.2K	﹤0.01%	1253

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

ExodusPoint Capital Management's OPTN Position: Q2 2023 in Review

ExodusPoint Capital Management sold out of OptiNose (OPTN) in Q2 2023, closing a stake of 898 shares — an estimated $26K sold.

ExodusPoint Capital Management first reported a position in OPTN in Q3 2019 and held it in 4 quarters. The position peaked at $234K in Q4 2020. 61 funds tracked by Wall St. Rank hold OPTN as of Q2 2023.

ExodusPoint Capital Management reported no remaining OptiNose position as of Q2 2023 after selling out during the quarter.
ExodusPoint Capital Management sold 898 OptiNose shares in Q2 2023, an estimated $26K.
ExodusPoint Capital Management first reported a position in OptiNose in Q3 2019 and held it in 4 quarters.
ExodusPoint Capital Management's OptiNose position peaked at $234K in Q4 2020.
61 funds tracked by Wall St. Rank held OptiNose as of Q2 2023.

Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.